Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

PNU-142633

From Wikipedia, the free encyclopedia
PNU-142633
Names
Preferred IUPAC name
(1S)-1-{2-[4-(4-Carbamoylphenyl)piperazin-1-yl]ethyl}-N-methyl-3,4-dihydro-1H-2-benzopyran-6-carboxamide
Other names
PNU-142633F
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C24H30N4O3/c1-26-24(30)19-4-7-21-18(16-19)9-15-31-22(21)8-10-27-11-13-28(14-12-27)20-5-2-17(3-6-20)23(25)29/h2-7,16,22H,8-15H2,1H3,(H2,25,29)(H,26,30)/t22-/m0/s1
    Key: PNTVCCRNJOGKGA-QFIPXVFZSA-N
  • InChI=1/C24H30N4O3/c1-26-24(30)19-4-7-21-18(16-19)9-15-31-22(21)8-10-27-11-13-28(14-12-27)20-5-2-17(3-6-20)23(25)29/h2-7,16,22H,8-15H2,1H3,(H2,25,29)(H,26,30)/t22-/m0/s1
    Key: PNTVCCRNJOGKGA-QFIPXVFZBB
  • NC(C(C=C1)=CC=C1N2CCN(CC[C@@H]3OCCC4=C3C=CC(C(NC)=O)=C4)CC2)=O
Properties
C24H30N4O3
Molar mass422.529 g·mol−1
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

PNU-142633 is anexperimental drug candidate for the treatment ofmigraine. It exerts its effect as aselective, highaffinity5-HT1D receptoragonist.[1][2] PNU-142633 is well tolerated after oral administration.[3]

It was an interesting candidate due to its greater affinity for5-HT1D compared to5-HT1B receptors (typical migraine drugs such as triptans are agonists for both receptors), but experimental results were disappointing.[4]

The structure can be compared favorably withSonepiprazole.

References

[edit]
  1. ^Pregenzer, JF; Alberts, GL; Im, WB; Slightom, JL; Ennis, MD; Hoffman, RL; Ghazal, NB; Tenbrink, RE (1999)."Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)".British Journal of Pharmacology.127 (2):468–72.doi:10.1038/sj.bjp.0702532.PMC 1566017.PMID 10385247.
  2. ^McCall, RB; Huff, R; Chio, CL; TenBrink, R; Bergh, CL; Ennis, MD; Ghazal, NB; Hoffman, RL; Meisheri, K; Higdon, NR; Hall, E (2002). "Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633".Cephalalgia.22 (10):799–806.doi:10.1046/j.1468-2982.2002.00459.x.PMID 12485205.
  3. ^Fleishaker, JC; Pearson, LK; Knuth, DW; Gomez-Mancilla, B; Francom, SF; McIntosh, MJ; Freestone, S; Azie, NE (1999). "Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F".International Journal of Clinical Pharmacology and Therapeutics.37 (10):487–92.PMID 10543315.
  4. ^The serotonin system : history, neuropharmacology, and pathology. M. D. Tricklebank, Eileen Daly. London, United Kingdom. 2019.ISBN 978-0-12-813324-8.OCLC 1105199268.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=PNU-142633&oldid=1301175000"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp